A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
Clinical trial NCT03675477 · COMPLETED
Trial details
- NCT number
- NCT03675477
- Sponsor
- Reistone Biopharma Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-13
- Primary completion
- 2020-11-30
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.